Sprout Pharmaceuticals Announces Release of Abstract Reporting Positive Interim Results for Flibanserin in Breast Cancer Patients Suffering from Low Libido for Poster Discussion at 2023 ASCO Annual Meeting

70% of women diagnosed with breast cancer report having sexual dysfunction, this includes disorders of sexual desire and sexual response. RALEIGH, N.C., June 2, 2023 /PRNewswire/ — Sprout Pharmaceuticals, Inc. a pharmaceutical company specializing in women’s sexual health today announced publication of abstract 12015 by the American Society of Clinical Oncology (ASCO). The abstract reporting … Read more

Thyme Care Joins CancerX Innovation Accelerator as Founding Member to Ignite Cancer Moonshot

National public-private partnership supports mission to slash cancer death rates by 50% over next 25 years; care navigation a crucial component for success Built by oncology industry veterans, Thyme Care joins initiative to help set the strategic direction and collaborate with key stakeholders to craft a cancer-free future Powered by a technology-enabled Care Team, Thyme … Read more

Exercise for stronger bones

For the head, muscles and bones! Regular physical activity helps strengthen our skeleton. And this, whatever our age. What mechanisms are present and what disciplines should be favored? Response elements. Our bone capital is built during our growth, with a so-called peak of “bone mass” reached around 15-16 years in girls. And 17-18 years old, … Read more

Los dispositivos de micromuestreo de Trajan cumplen la normativa IVDR en Europa y Reino Unido

Mitra® y hemaPEN ® reciben la certificación reglamentaria como productos sanitarios para la extracción remota de muestras de sangre en la asistencia sanitaria, los ensayos clínicos y los programas de monitorización domiciliaria en Europa y Reino Unido MELBOURNE, Australia, 2 de junio de 2023 /PRNewswire/ — Trajan Scientific and Medical, proveedor líder de productos y soluciones … Read more

Trajan’s Microsampling Devices Meet IVDR Compliance in Europe, UK

Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home monitoring programs in Europe and United Kingdom. MELBOURNE, Australia, June 2, 2023 /PRNewswire/ — Trajan Scientific and Medical, a leading provider of analytical and life sciences products and solutions, today announced the regulatory approval of … Read more